TFB Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

TFB Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$410K	Buy	+1,771	New	+$438K	0.17%	135

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $53.5B AUM 32.01% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

TFB Advisors's JAZZ Position: Q3 2026 in Review

TFB Advisors opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2026: 1,771 shares worth $410K. The stake represents 0.17% of the portfolio and ranks #135 among its holdings.

394 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

TFB Advisors held 1,771 shares of Jazz Pharmaceuticals worth $410K as of Q3 2026.
Jazz Pharmaceuticals was a new TFB Advisors position in Q3 2026.
Jazz Pharmaceuticals made up 0.17% of TFB Advisors's portfolio in Q3 2026, its #135 holding.
394 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on TFB Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.